According to the online healthcare provider, RTKis (pronounced as Ar-Tee-kis) provides a cost-effective, credible, and convenient means to comply with guidelines set by the Ministry of International Trade & Industry (MITI) for economic sectors allowed to operate under Phase 2 of the National Recovery Plan. The system takes advantage of the self-test kits recently approved by the Medical Device Authority (MDA) which allows individuals to take Antigen Rapid tests in the comfort of their homes. Basically, after users conduct the self-test, they can then submit the results on RTKis which uses artificial intelligence to validate the test results. Positive results will be uploaded to the Public Health Laboratory Information System (SIMKA) which is synchronised with MySejahtera.
DOC2US says that the use of AI, in addition to the unique QR codes that come with each RTK antigen test kit sold under their package, will minimise the risks of fraud from self-declaration. Their anti-fraud measures also include phone number verification, identity verification through identity card, and requiring users to take photos and videos of the test process. “Our AI-powered system is using image classification engine with machine learning to identify the test result based on the uploaded test kit photo,” said DOC2US Chief Technology Officer Tan Aik Keong, who developed the backend system.
Currently, RTKis only works with Gmate, a saliva-based COVID-19 self-test kit imported from South Korea. That being said, Dr Raymond Choy, Chief Executive Officer of DOC2US, adds that their system is designed to work with other test kits as well. Another test kit, locally-manufactured Salixium, also claims to have a companion app that integrates with MySejahtera, although it has yet to be launched. DOC2US’ RTKis package is sold at RM45 each. (Source: DOC2US [Official website])
